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Directed cell migration polarizes the cytoskeleton, allowing the cell to move towardmigratory cues.
In this issue, Wu et al. (2011) demonstrate that the glycogen synthase kinase 3b (GSK3b) controls
microtubule architecture and polarized movement of skin stem cells during wound healing in
mammals by regulating the microtubule crosslinking protein ACF7.Development, inflammation, and wound
healing all critically depend upon directed
cell migration when effector cells move
toward particular extracellular cues. For
example, when skin is injured, stem cells
travel from the hair follicle to the wound to
rebuild the skin epithelium. Directed cell
migration requires changes in the cell’s
polarityand remodelingof thecytoskeleton
(Ridleyet al., 2003), including the regulation
ofmicrotubule, actin, and intermediate fila-
ments at the front of the cell (Figure 1).
These dynamic structures mediate
changes in cellular shape, but they also
form a platform for receiving and gener-
ating key morphogenic signals.
What cytosolic factors transmit migra-
tory cue information from the cellular
membrane to these signaling centers on
the cytoskeleton? Although this complex
process probably depends on many
genetically redundant factors, several
kinases and phosphatases are emerging
as key players. Initial reports have
solidified roles for phosphatidylinositol
3-kinase (PI3K) and the lipid phospha-
tase PTEN in defining the front and
backsides of migrating cells, respec-
tively. Now Wu et al. (2011) find that
another workhorse kinase, glycogen syn-
thase kinase 3b (GSK3b), orchestrates
polarization and reorganization of micro-
tubules in hair follicle stem cells during
wound healing. This study, along with
another recent report by Zaoui et al.
(2010), demonstrates that GSK3b
governs microtubule elongation through
its control of the microtubule-actin
crosslinking protein ACF7 (actin cross-
linking factor-7/microtubule and actin
crosslinking factor-1).GSK3b is a serine-threonine kinase that
participates in numerous growth factor
and morphogen signaling pathways,
including the canonical Wnt pathway. In
addition, GSK3b has been implicated in
a variety of diseases, such as diabetes,
Alzheimer’s disease, bipolar disorder,
and cancer (Rayasamet al., 2009). Recent
studies have found that GSK3b is a central
regulator of cell polarity and cytoskeleton
dynamics. The kinase regulates the poly-
merization of filamentous actin (F-actin)
at the front and periphery of the cell by
activating the Rho GTPase Rac and
ADP-ribosylation factor 6 (Arf6), and by
repressing p190a-RhoGAP and APC
(adenomatous polyposis coli). Further,
GSK3b modulates cell-matrix adhesions
by activating paxillin and inhibiting focal
adhesion kinase (Sun et al., 2009).
A fascinating link has also recently
emerged between GSK3b and proteins
that associate with the plus (+) ends of
microtubules, called ‘‘+tip proteins.’’ The
+tip proteins regulate the growth of the
noncapped, (+) ends of microtubule fila-
ments at the front of migrating cells
(Figure 1). The +tip proteins also interact
with membrane proteins, such as Rho
GTPases, to relay extracellular migratory
signals to microtubules (Sun et al., 2009).
Recent studies indicate that GSK3b phos-
phorylates and inactivates certain +tip
proteins, such as CLASP2, providing a
link between GSK3b kinase and microtu-
bule elongation (Kumar et al., 2009).
Another key class of +tip proteins is
spectraplakins. The twomammalianspec-
traplakins, BPAG1/dystonin and ACF7/
MACF, are large proteins (>500 kDa) that
orient the cytoskeleton by binding andCell 144crosslinking actin and microtubule fila-
ments. These spectraplakins also form
membrane subdomains and scaffolds
for signaling complexes. Mice lacking
BPAG1 display skin blistering due to the
epidermis splitting from the dermis (Roper
et al., 2002). In contrast, lossof ACF7 in the
epidermis causes no skin or hair pheno-
type but delays wound repair. Keratino-
cytes with mutations in ACF display 80%
lessmovement thanwild-typecontrol cells
in scratch wound assay in vitro. This
phenotype was previously ascribed to
defective coordination of microtubule
growth along F-actin filaments and stabili-
zation of focal adhesions (Wu et al., 2008).
NowWu et al. and Zaoui et al. elegantly
link GSK3b activity with the regulation
of ACF7-associated microtubules and di-
rected cell migration. Wu and colleagues
investigate the wounding phenotype of
mice with mutations in the ACF gene
and find a significant delay in wound
closure. They found that phosphorylation
of the carboxyl terminus of ACF7 by
GSK3b diminishes ACF7’s binding to
microtubules. In addition, using a phos-
pho-specific antibody, the authors show
that phospho-ACF7 localizes to the cyto-
plasm but not to microtubules, confirming
that phosphorylation of ACF7 uncouples
the +tip protein from microtubules
(Figure 1). Next, the authors generate
amutant version of ACF7 that is refractory
to phosphorylation by GSK3b, and in-
deed, this mutant rescues portions of
the ACF7 mutant phenotype.
Similarly, Zaoui and colleagues investi-
gate GSK3b’s role in the migration of
breast cancer cells responding to the
epidermal growth factor (EGF) ligand, February 4, 2011 ª2011 Elsevier Inc. 319
Figure 1. GSK3b Is a Central Regulator of the Cytoskeleton during
Cell Migration
In nonmigrating cells, GSK3b is normally active and phosphorylates proteins
that associate with the plus (+) ends of microtubule filaments, called ‘‘+tip
proteins.’’ Phosphorylation uncouples +tip proteins from microtubules (Wu
et al., 2011), inhibiting growth of the filaments. Migratory cues, such as
Heregulin, inactivate GSK3b by phosphorylation (Zaoui et al., 2010), allowing
the local extension of microtubules by +tip proteins. This helps to polarize the
cytoskeleton and direct cellular movement toward the migratory cues.Heregulin through stimulation
of the tyrosine kinase re-
ceptor ErbB2. The group
had previously shown that
Heregulin induces directed
cell protrusions by
triggering the Memo (medi-
ator of ErbB2 motility)
membrane complex at the
leading edge. In addition,
they found that +tip proteins
APC and CLASP2 mediate
microtubule formation at cell
protrusions during these
cells’ migration. In their most
recent study, Zaoui and
colleagues demonstrate that
Memo inactivates GSK3b,
and this inhibition, in turn,
targets APC and CLASP2 to
the membrane. In addition,
Heregulin activity localizes
ACF7 to the plasma mem-
brane and microtubules, and
this localization depends on
GSK3b and APC.
Together, the data pre-
sented byWu et al. and Zaoui
et al. strongly link GSK3b
activity and the phosphoryla-
tion status of ACF7 with cell
migration and ACF7 associa-
tion with microtubules. How-
ever, the biochemical mecha-
nism of ACF7 regulation byGSK3b remains mysterious. Wu and
colleagues report that neither the kinase-
refractile nor the phosphomimetic
mutants of ACF7 could rescue the polarity
and directional movement defect in ACF7
mutant hair follicle stem cells. This
surprising result portends that regulation
of ACF7 by GSK3b is more complex
than simply inhibition by phosphorylation
and suggests that subsets of the multiple
phosporylation sites on ACF7 may have
distinct functions. Indeed, such behavior
has been observed for the +tip protein
CLASP2 (Kumar et al., 2009). Alterna-
tively, cycling of ACF7 phosphorylation
status may be needed for prolonged
microtubule elongation. Experiments
examining the phosphorylation and func-
tion of ACF7 (and other +tip proteins) in
single-molecule, dynamic microtubule
assays will be necessary to understand
precisely how GSK3b operates at the
leading edge.320 Cell 144, February 4, 2011 ª2011 ElsevieThese two studies also generate many
additional questions about how migratory
cues sculpt the cytoskeleton through key
kinases, such as GSK3b. One central
question is the nature of the interactions
between +tip proteins and how their local-
ization on microtubules regulates actin
and microtubule architecture, cell migra-
tion, and polarity. The complex of ACF7
and another +tip protein, EB1 (end-
binding protein 1), appears necessary
and sufficient for microtubule elongation
in some cells in culture, but how the other
+tip proteins function in different physio-
logical contexts remains unexplored.
Mice with mutations in ACF7 develop
normal skin morphology, suggesting that
other spectraplakins or +tip proteins
must control the polarized growth of the
hair follicle or developing skin epithelium.
Another open question is how the
signaling pathways of PI3K intersect with
those of GSK3b in generating cell polarity.r Inc.It is well-known that PI3K
regulates GSK3b (Cross
et al., 1995), but it is still
unknown whether migratory
cues necessarily regulate
PI3K, GSK3b, or both kinases
simultaneously. Having cues
affect different kinases could
allow for greater complexity
of cell shapes and motility
outcomes.
Finally, identifying endoge-
nous migratory cues that
control directional migration
through GSK3b may lead to
the discovery of new thera-
peutic agents. Heregulin and
other EGF ligands are well-
known migratory cues in
wound healing and develop-
ment. They appear, at least
in breast cancer cells, to
be a migratory cue that alters
the cytoskeleton by acting
through GSK3b (Zaoui et al.,
2010).
In addition, Wnt ligands are
certainly present in wounded
skin, and noncanonical Wnt
signaling to the cytoskeleton
through Rho kinase plays a
well-established role in mor-
phogenic processes, such as
convergent extension during
gastrulation (i.e., when tissuerestructures to extend along a perpendic-
ular axis). However, a clear role for canon-
ical Wnt signaling through GSK3b is
currently lacking for wound healing in
skin (Ito et al., 2007). Nevertheless, given
the central role of GSK3b and +tip
proteins in regulating the cytoskeleton
during directed cell migration, additional
roles in establishing the cytoskeleton’s
global positional device system are sure
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The nutrient sensor O-GlcNAc transferase modifies proteins with the O-GlcNAc moiety. In this
issue, Capotosti et al. (2011) reveal that O-GlcNAc transferase not only glycosylates the cell-cycle
regulator host cell factor 1 but activates it through proteolytic cleavage, providing a surprising link
between metabolism and epigenetic regulation of the cell cycle.Host cell factor 1 (HCF-1) is an evolution-
arily conserved epigenetic regulator that
undergoes an unusual proteolytic pro-
cessing event to generate stably associ-
ated fragments that regulate different
stages of the cell cycle (Kristie et al.,
2010). In vertebrates, the molecular iden-
tity of the factor responsible for HCF-1
cleavage has been cloaked in mystery.
With a plot twist worthy of a best-selling
detective novel, Capotosti et al. now
unmask an unexpected culprit—the
nutrient-sensing epigenetic regulator
O-linked GlcNAc transferase (OGT)
(Figure 1). Their findings provide com-
pelling evidence that OGT has a dual
enzymatic role, catalyzing both O-GlcNA-
cylation and cleavage of HCF-1. This part-
nering of two epigenetic regulators to
control cell-cycle progression has impor-
tant implications for fields as diverse as
viral pathogenesis, stem cell biology, and
diseases of aging including cancer, dia-
betes, and neurodegeneration.
Although the HCF-1 protein was origi-
nally identified as a target for the Herpes
simplex virus VP16 transcriptional acti-
vator, subsequent work has shown thatHCF-1 normally coordinates passage
through the cell cycle (Goto et al., 1997).
The N-terminal subunit, HCF-1N, pro-
motes progression through G1, whereas
the C-terminal subunit, HCF-1C, regulates
mitosis and cytokinesis. In vertebrates,
these domains are separated by six
conserved HCF-1PRO repeats, which
contain many proline and threonine resi-
dues and an invariant glutamate that
marks the site of proteolysis. Cleavage
at this site is required for HCF-1 regulation
of M phase events. Although HCF-1
activity in all animals is regulated by prote-
olysis, the HCF-1 sequence differs greatly
between invertebrates and vertebrates
such that different animal lineages employ
distinct mechanisms for HCF-1 process-
ing. Lower metazoans employ a threo-
nine-directed endopeptidase (taspase)
to sever the two HCF-1 subunits, but
vertebrates use a different strategy (Ca-
potosti et al., 2011).
Multiple pieces of evidence hint that
posttranslational modification of HCF-1
might be important for cleavage. Capo-
tosti et al. show that inhibitors of phos-
phorylation do not alter processing, buta presumptive OGT inhibitor and deple-
tion of OGT by RNA interference prevent
HCF-1 maturation. Although O-GlcNAcy-
lation of HCF-1 depends on the presence
of the threonine-rich HCF-1PRO repeats, it
is several threonines in the HCF-1N
N-terminal subunit that are glycosylated.
OGT does more than simply glycosylate
HCF-1 before it is cleaved. Capotosti
et al. show that OGT glycosylates and
then remains bound to a cleavage-resis-
tant HCF-1 mutant. Furthermore, they
find that purified recombinant OGT
cleaves the HCF-1PRO repeat in vitro.
The authors suggest thatO-GlcNAc-cata-
lyzed autoproteolysis of HCF-1 does not
efficiently cleave HCF-1PRO repeats
in vitro. Providing an in vivo validation of
this conclusion, the authors replace the
vertebrate HCF-1PRO domain with a tas-
pase cleavage site. Although this variant
is efficiently processed by taspase, it is
neither recognized nor cleaved by OGT,
and this heterologous HCF-1 does not
rescue HCF-1 function. Together, these
data strongly suggest that OGT-depen-
dent glycosylation and cleavage are
critical for the M phase functions of, February 4, 2011 ª2011 Elsevier Inc. 321
